Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you have come across the term "ASFA" alongside Mounjaro and wondered what it signals, you are not alone. ASFA stands for Alternative Supplier Formulation or Allocated Supply Fulfillment Arrangement, depending on the context — but in UK pharmacy use it most commonly flags a product sourced or allocated outside the standard licensed UK supply route. Mounjaro (tirzepatide), manufactured by Eli Lilly, is a prescription-only medicine. Any supply must reach you through the licensed UK supply chain and via a valid prescription issued after clinical assessment. The decision worth making carefully here is not just where to source Mounjaro, but whether the supply route is one you can genuinely trust.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The term ASFA is not part of Mounjaro's licensed product information. When it appears on a listing or in a pharmacy description, it is usually a signal about how that particular stock was procured rather than what the medicine itself is. In the UK, Mounjaro should reach patients through Eli Lilly's authorised distribution channels. Stock described as ASFA, parallel-imported, or sourced via alternative fulfilment routes sits in murkier regulatory territory, and the critical question is whether it has arrived through a route that the MHRA and the licensed supply chain can account for.
This is not a trivial distinction. Counterfeit tirzepatide pens have been found in UK circulation, and in October 2025 the MHRA uncovered the first illicit domestic site manufacturing fake Mounjaro pens, in Northampton. Enforcement that year also saw around 20 million doses of illegally traded weight-loss medicines (worth approximately £45 million) seized. If a label, listing or seller cannot clearly confirm licensed UK supply, that gap should give you pause. The MHRA's Yellow Card scheme exists partly so that patients can report suspect sellers, and it is worth knowing it is there.
A supply described as ASFA is not automatically unsafe, but it is a prompt to ask harder questions before accepting it.
When people search for Mounjaro ASFA, they are often trying to work out whether a cheaper or more readily available supply is legitimate. It is an understandable thing to weigh up, particularly if you have been waiting for stock or have found prices vary considerably between providers. The honest answer is that for a prescription-only medicine, the right question is not which listing is cheapest but which supply route can be verified.
You can verify any online pharmacy operating in the UK through the GPhC's public register. A GPhC-registered pharmacy must dispense only against a valid prescription, source medicines through the licensed UK supply chain, and have a responsible pharmacist accountable for every dispensing decision. If a seller cannot be found on that register, or if they are offering Mounjaro without requiring a prescription from a registered prescriber, those are reliable red flags, not points to rationalise away.
For context on what private Mounjaro treatment typically costs through a legitimate pharmacy, our Mounjaro cost guide sets out the market honestly, including the price changes that followed Eli Lilly's September 2025 list-price revision.
Before supply-chain questions even arise, there is a prior one: is Mounjaro right for you clinically? The medicine is licensed for adults whose BMI is 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, high cholesterol, type 2 diabetes, or obstructive sleep apnoea. NICE's appraisal of tirzepatide, TA1026, sets out the evidence base, and the NHS's own pages on tirzepatide explain the clinical picture in plain terms.
A prescriber also looks at the whole picture: your medical history, current medicines, and any contraindications. Mounjaro is not appropriate during pregnancy, while breastfeeding, or for anyone under 18. People with a history of medullary thyroid carcinoma or certain gastrointestinal conditions need specific clinical discussion before starting. None of that assessment can happen from a listing or a supply arrangement. It requires a prescriber who has actually read your information.
If you are exploring tirzepatide as a treatment option, understanding what the licensed starting dose is designed to do can also help frame realistic expectations. The lowest strength, 2.5mg, exists to let your body adjust gradually, its purpose is tolerability, not the therapeutic effect that comes at higher doses over time, and you can find a fuller breakdown of how the dose progression works on our Mounjaro 5mg page. More detail on the early weeks is on our 2.5mg Mounjaro page.
You may be feeling a mixture of things right now: hopeful about what Mounjaro might do, but cautious (maybe a little sceptical) about whether online pharmacies are really safe. That caution is well-placed, and it is worth describing what a legitimate route genuinely involves, so you have something concrete to compare against.
A properly regulated UK pharmacy will require a prescription issued by a registered Independent Prescriber who has personally reviewed your consultation. They will dispense only from the licensed UK supply chain. They will carry out identity verification, not just ask you to tick a box. They will notify your GP in line with GPhC guidance. And the medicine that arrives will be in the manufacturer's original, temperature-controlled packaging, not a pen that has travelled an opaque route through unknown hands.
At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber on the day you submit it. Our pharmacy's registration (number 9012878) is publicly verifiable on the GPhC register. Medicines are sourced through Eli Lilly's authorised UK supply. You can read more about how Mounjaro works, about tirzepatide vaistai and the broader range of tirzepatide medicines available, and about our approach to weight management before deciding whether to take the next step.
If you are ready to find out whether Mounjaro is clinically suitable for you, speak to our prescribers through a free consultation, no waiting lists, no referral required.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.